title: The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin.
authors.forename: P
authors.initials: P
authors.lastname: Fontana
authors.forename: P
authors.initials: P
authors.lastname: Alberts
authors.forename: K S
authors.initials: KS
authors.lastname: Sakariassen
authors.forename: H
authors.initials: H
authors.lastname: Bounameaux
authors.forename: J-P
authors.initials: JP
authors.lastname: Meyer
authors.forename: A
authors.initials: A
authors.lastname: Santana Sorensen
mesh_terms: D001241:Aspirin / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D017482:Receptors, Thromboxane / Q000037:antagonists & inhibitors*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D004791:Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D017482:Receptors, Thromboxane; D013930:Thromboxane-A Synthase; D001241:Aspirin